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Effects of environmental chemicals
on kidney metabolism and function
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Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan
The mammalian kidney, because of its high rate
of perfusion, active transport capabilities, and con-
centrating functions, often is exposed to much high-
er concentrations of chemicals than are other or-
gans. These high concentrations of chemicals may
have no effect on the kidney, may produce a benefi-
cial therapeutic response, or may produce harmful
(toxic) effects to the organ.
Some chemicals may produce a direct renal cyto-
toxicity, such as that produced by heavy metals
(mercury, chromium), by therapeutic agents
(aminoglycoside antibiotics, analgesics), or by a va-
riety of widely used chemicals (chloroform, carbon
tetrachloride). Certain other chemicals in the envi-
ronment may produce biochemical changes in the
kidney that alone appear to have no functional cor-
relation (that is, no functional nephropathy can be
measured) yet may alter the response of the kidney
to other agents. The former chemicals produce
identifiable functional lesions that may be life-
threatening. Their effects are predictable and dose-
related, however. Judicious use of therapeutic
agents, careful monitoring of the work place, and so
forth, can minimize the dangers of these com-
pounds to man. The latter chemicals, on the other
hand, produce no functional lesion and are, there-
fore, more insidious in their effects and may present
more of a hazard to man.
The kidney is capable of metabolically altering a
wide variety of endogenous and exogenous chem-
icals. Although many of these reactions produce
compounds with reduced biological activity, in
some specific instances metabolic transformation of
a chemical may result in a compound with greater
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(or different) biological activity. Metabolism of
chemicals within the kidney may, therefore, be an
important factor in determining the response of the
kidney to chemical exposure. The subject of this
article will be the relationships between exposure to
environmental pollutants and changes in renal bio-
chemistry that may adversely affect kidney func-
tion.
Metabolism and chemical toxicity
Because of its relatively large size, high metabol-
ic activity, and anatomical location, the liver is the
primary organ of metabolism of chemicals. It acts
as a barrier, of sorts, to the distribution of lipophilic
agents to the rest of the body. The liver is particu-
larly effective in metabolizing orally-ingested chem-
icals, for venous blood draining the gastrointestinal
tract via the hepatic portal vein is delivered directly
to the liver. Thus, the liver is able to degrade many
toxicants before they can exert systemic effects.
Enzymes capable of metabolizing xenobiotic (for-
eign) chemicals also exist in many nonhepatic tis-
sues, including kidney, lung, brain, intestine, adre-
nal gland, gonads, and placenta. The total activities
of nonhepatic enzyme systems, in general, are
much lower than are those of the liver, and they
probably contribute little to the overall rate of elimi-
nation of xenobiotic chemicals from the body. Or-
gan-specific metabolism is, however, an important
determinant of the local concentrations of xenobiot-
ic toxicants and their metabolites—concentrations
that can determine the degree of injury produced by
toxicant exposure. Thus, intraorgan metabolism
can be an important process in the pathophysiology
of chemical toxicity.
Xenobiotic metabolism has frequently been con-
sidered as a degradative process, largely because
the excretion of lipophilic compounds is hastened,
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and the pharmacologic activities of many drugs are
reduced, by enzymatic biotransformation. More
specifically, however, the primary function of xeno-
biotic metabolism is to convert nonpolar substrates
to polar products that will not be reabsorbed from
urine or bile. In certain instances, the products of
metabolism, though more polar than the parent
compounds, may be more potent toxicants. The
oxidative dehalogenation of chlorinated hydrocar-
bons and epoxidation of polycyclic aromatic hydro-
carbons, for example, often produce products more
toxic than the parent compounds. Thus, xenobiotic
metabolism can be a toxification as well as a detoxi-
fication process.
Balance between enzymatic toxjflcation and de-
toxification. The degree of tissue injury produced
by exposure to a toxic chemical is a function of the
inherent sensitivity of the affected tissue to the
presence of the chemical and the concentration of
that chemical and its metabolites in the tissue. In-
herent sensitivity is determined by the relative seri-
ousness of the molecular lesion produced by the
toxicant and by the ability or the inability of the tis-
sue to repair the damage produced, neither of which
are significantly affected by xenobiotic metabolism.
The concentration of the toxic species in the tissue,
however, can be influenced by xenobiotic metabo-
lism. Thus, the metabolic disposition of a chemical
and its metabolites can greatly affect toxicity. The
availability of the substrate (that is, the parent
xenobiotic molecule) is affected by the excretion of
the parent compound in an unchanged form and by
the existence of competing pathways of metabo-
lism. In addition, metabolites may subsequently be
enzymatically metabolized to secondary products.
These principles have been reviewed recently by
Jollow and Smith [1] and are illustrated in Fig. I.
The relative rates of metabolism of xenobiotic
chemicals to toxic and nontoxic products produce a
balance between enzymatic toxification and detoxi-
fication reactions and may determine, to a large ex-
tent, the response of an organism to toxicant ex-
posure. Alterations in the relative activities of (that
is, balance between) pathways 1, 2, 3, and 4 in Fig.
I could alter the amount of metabolite (the toxic
metabolite) present in the tissue and, therefore, the
degree of injury produced. Reactions depicted by
pathway 3 are generally catalyzed by P-450-depen-
dent, microsomal mixed-function oxidases (MFO's)
and those of pathway 2 by MFO's or nonoxidative,
cytosolic enzymes. Pathway 4 enzymes frequently
catalyze conjugation reactions or the hydration of
epoxides.
Excretion (unchanged)
A
3
2 Metabolite A
(nontoxic)
4 Metabolite CMetabolite B (toxic)
Fig. 1. Potential metabolic alterations of a xenobiotic chemical.
Reactive metabolites and tissue injury. Many
recognized chemical carcinogens bond covalently
to cellular macromolecules. A popular theory sug-
gests that the alkylation or arylation of critical mac-
romolecules is the initiating event in the neoplastic
transformation of mammalian cells by carcinogenic
chemicals [2, 3]. The carcinogenic potential of
many compounds, therefore, is achieved by metab-
olism of the parent molecule to a chemically reac-
tive species capable of extracting or donating elec-
trons to nuclear materials. The covalently bound
adduct is then thought to interfere with normal
chromatin function.
More recently, the metabolism of chemicals to
toxic, reactive intermediates has been implicated in
chemically induced mutagenesis, teratogenesis,
necrogenesis, and other disorders [4, 5]. Relation-
ships between the formation of reactive metabolites
and the development of acute tissue injury have
been studied extensively in the rodent liver, where
positive correlations between the covalent binding
of reactive metabolites to hepatic proteins and lip-
ids and hepatotoxicity have been demonstrated [6,
7]. Correlations between the binding of metabolites
to kidney and chemical nephrotoxicity have also
been reported [8, 9]. Though direct cause-and-effect
relationships between alkylation and acute tissue
injury have not been demonstrated unequivocally,
many investigators have proposed that such a rela-
tionship exists [6, 7, 10].
The adjective reactive implies that the molecule
so described is chemically unstable and will quickly
react with suitable, near-by molecules to achieve a
more stable configuration. This generally involves
650 K/uwe and hook
the sharing of electrons and the formation of a cova-
lent bond. The polarity and instability of reactive
metabolites generally precludes passage across lipid
membranes and extensive half-lives. Thus, reactive
metabolites are thought to be formed in close prox-
imity to the sites of macromolecular alkylation. The
presence of covalently bound metabolites within
the kidney, therefore, suggests that activation oc-
curred directly in the kidney.
Renal metabolism and chemical nephrotoxicity
The relatively low in vitro activities of renal micro-
somal MFO's, in comparison to those of the liver,
might suggest that little activation of toxicants oc-
curs in the kidney. An explanation for the low ap-
parent activities of MFO's in renal microsomal prep-
arations, however, might be that such enzymes are
confined to a relatively small population of renal
cells. MFO's appear to be components of the mem-
brane of the smooth endoplasmic reticulum, an or-
ganelle found in highest renal concentrations in the
S3 cells of the proximal tubules. The concentration
of S3 cells is greatest in the pars recta [11], that por-
tion of the proximal tubule with the greatest suscep-
tibility to toxicant damage [12]. If P-450-dependent
MFO's are largely confined to this renal cell type,
then homogenates of whole kidney or kidney cor-
tex, either of which contain greatly diluted contents
of S3 cells, understandably exhibit low activities to-
wards most substrates for hepatic microsomal oxi-
dation. Indeed, Fowler, Hook, and Lucier [13] have
demonstrated that the anatomical distribution of
MFO activities within the kidney grossly corre-
sponds to the intrarenal distribution of S3 cells. In
addition, Zenser, Mattammal and Davis [14] have
reported that renal MFO activities and P-450 con-
centrations exhibit a cortical-papillary gradient
(highest in the cortex and outer medulla, lowest in
the papilla), a pattern similar to the distribution of
S3 cells in the kidney. It has also been reported that
treatment of rats with 2,3,7,8-tetrachlorodibenzo-p-
dioxin, a microsomal enzyme stimulator, greatly in-
creased MFO activities in the kidney and increased
the amount of smooth endoplasmic reticulum in S3
cells, though anatomically-adjacent S2 cells and dis-
tal tubular cells were not affected [13]. These stud-
ies suggest that P-450-dependent microsomal MFO
activities in S3 cells may be quantitatively similar to
those in hepatic parenchymal cells and indicate that
the kidney can, indeed, activate nephrotoxicants. It
follows, therefore, that concentrations of metabo-
lites sufficiently high to cause toxicity could be gen-
erated in specific cells of the nephron.
Figure 1 emphasizes that the quantitative nephro-
toxicity of certain chemicals can be influenced by
the balance between enzymatic toxification and de-
toxification reactions. Therefore, factors that con-
trol the activities of xenobiotic metabolizing en-
zymes can be important determinants of the sensi-
tivity of the kidney to the nephtotoxic effects of
chemicals. The basal activities of xenobiotic metab-
olizing enzymes are influenced by genetic, hormo-
nal, and nutritional factors. The most dramatic
changes in enzyme activities, however, are pro-
duced by exposure of experimental animals to
chemicals that increase or decrease the activities of
microsomal enzymes. A few inducers (for example,
phenobarbital, 3-methylcholanthrene) and inhib-
itors (for example, SKF 525-A, piperonyl butoxide)
have been used extensively by experimental phar-
macologists to investigate the effects and mecha-
nisms of drugs that are activated or deactivated by
enzymatic metabolism. Many others, some halo-
genated aromatic hydrocarbons, for example, are
common environmental pollutants in addition to
being potent inducers of enzyme activities.
A list of common chemical pollutants that in-
crease renal enzyme activities is shown in Table 1.
The brevity of this list, in comparison to one that
could be prepared for liver, is probably a con-
sequence of a lack of experimental inquiry rather
than of the noninducibility of kidney enzymes. A
potential exists for inducers or inhibitors of renal
xenobiotic metabolism to upset the balance be-
tween toxification and detoxification reactions in
the kidney and to alter the sensitivity of the kidney
to the toxic effects of certain chemicals. In addition,
the induction of renal enzyme systems may alter the
normal biosynthesis and degradation of endogenous
compounds such as the prostaglandins and 1, 25-
dihydroxycholecalciferol. Several examples of the
effects of common environmental pollutants on re-
nal microsomal enzyme activities and renal func-
tion, including response to chemical nephrotoxi-
cants, are discussed in the following paragraphs.
Polybrominated biphenyls (PBB's). PBB's became
of toxicologic concern following an agricultural ac-
Table 1. Environmental pollutants that increase renal xenobiotic
metabolizing enzyme activities
3 ,4-Benzo(a)pyrene
Chlorinated dibenzodioxins (TCDD)
Dichiorodiphenyltrichioroethane (DDT)
3-Methylcholanthrene (3 MC)
Polybrominated biphenyls (PBB's)
Polychiorinated biphenyls (PCB's)
Hexachlorobenzene
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cident in the state of Michigan that resulted in hu-
man consumption of PBB's in meat and dairy prod-
ucts [15]. The particular formulations involved,
Firemasters BP-6 and FF-l (Velsicol Chemical
Company, St. Louis, Missouri), were complex mix-
tures of brominated biphenyls (mostly hexabro-
mobiphenyl). PBB molecules are nonpolar, lipo-
philic, and resistant to enzymatic degradation. They
are, therefore, well absorbed following oral inges-
tion, rapidly partitioned into fatty tissues, and ex-
creted very slowly. Estimated tissue half-lives are
as long as 7 to 10 years.
The forced feeding of large amounts of PBB (25 g/
day) to cows produced dilatation of renal tubules
and collecting ducts and elevations of serum urea
nitrogen and urine protein concentrations [16]. The
cows also appeared emaciated, however, and the
relative contributions of PBB treatment and body
wasting to the reported symptoms are difficult to
distinguish. Lower doses (0.25 g/day) produced no
kidney abnormalities. Rats ingesting 5 mg/kg/day
of PBB for up to 3 months exhibited normal renal
function. No changes were detected in the follow-
ing: the clearance of PAH and the clearance of in-
ulin; fractional sodium excretion; renal ammonio-
genesis and gluconeogenesis; and the in vitro accu-
mulation of organic acids by slices of kidney cortex.
Renal morphology was also normal. Renal micro-
somal MFO activities, however, were sharply ele-
vated [17]. PBB induced renal enzymes in a selec-
tive manner; aryihydrocarbon hydroxylase (AHH)
activity was increased several fold, whereas epox-
ide hydratase (EH) was reduced or unaffected [17].
This phenomenon was judged to be of toxicologic
concern by the authors because many aromatic hy-
drocarbons are believed to be enzymatically tox-
ified by AHH to reactive epoxides and detoxified by
EH to dihydrodiols (pathyways 3 and 4, respective-
ly, of Fig. 1). Unfortunately, the effects of PBB on
only a limited number of enzymes are known.
These results, indicate, however, that PBB may up-
set balances between toxification and detoxification
reactions by selectively inducing specific micro-
somal enzyme activities.
One group of nephrotoxic chemicals in which me-
tabolism is believed important in determining toxicity
is halogenated aliphatic hydrocarbons. Chloroform
and carbon tetrachloride, for example, are thought
to be converted to toxic products via microsomal
metabolism [18, 19] These compounds, therefore,
were used as models with which to ascertain the ef-
fects of PBB-induced enzyme stimulation on kidney
metabolism and response to toxicants. Dietary in-
gestion of PBB by mice increased renal enzyme ac-
tivities in a concentration-dependent manner. In-
creases in renal AHH activity were proportional to
the concentration of PBB in the diet following 14
days of exposure to 0, 1, 25, and 100 ppm of PBB
(Table 2). Chloroform nephrotoxicity was also en-
hanced by PBB ingestion and the degree of en-
hancement was proportional to the concentration of
PBB in the diet (Table 3). These results suggest that
PBB ingestion, in subtoxic amounts, stimulated the
metabolism of chloroform to a nephrotoxicant and
thereby enhanced the sensitivity of the kidney to
chloroform-injury.
Ingestion of PBB was also shown to enhance the
nephrotoxicity of other halogenated hydrocarbons.
Carbon tetrachioride, trichloroethylene, and 1,1,2-
trichloroethane produced more renal injury in PBB-
treated mice than they did in control mice [20].
Thus, PBB exposure may enhance the sensitivity of
the kidney to the nephrotoxic effects of chlorinated
aliphatic hydrocarbons.
The nephrotoxicity of acetaminophen (APAP) is
considered to be associated with the action of a re-
active metabolite, which may also be responsible
for reducing renal concentration of nonprotein sul-
phydryl groups (primarily glutathione). The ability
of APAP to deplete nonprotein suiphydryls in the
isolated perfused rat kidney was enhanced by prior
treatment of the donor rats with PBB and was re-
duced by piperonyl butoxide (Table 4). More re-
cently, mercapturic acid conjugation of APAP (pre-
sumed to be indicative of the conjugation of a reac-
tive intermediate with glutathione) by the isolated
perfused rat kidney was enhanced threefold to four-
fold by PBB, whereas formation of the nontoxic
glucuronide and sulfate conjugates were decreased
by 20% (Newton et al, unpublished observations).
Polychiorinated biphenyls (PCB's). PCB's are
similar to PBB's in many respects. They are com-
Table 2. Induction of arylhydrocarbon hydroxylase (AHH)
activity by polybrominated biphenyls (PBB)
.
DietaryPBB
ppm
AHHactivitya
Kidney Liver
0 0.08 0.01 12.1 2.1
1 0.09 0.01 14.6 2.3
25 0.12 001b 26.7 2•7b
100 0.25 002b,c 53.2 41b.a
a AHH activity is measured in relative fluorescence units per
milligram of protein per minute. Values are the mean SEM of
six animals that had received treated diet for 14 days.
b Significantly greater than 0 ppm, P < 0.05
Significantly greater than 25 ppm, P < 0.05
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plex mixtures of halogen-substituted biphenyls and
related compounds, they are lipid soluble, resistant
to metabolic degradation, and they are accumulated
in fatty tissues. The halogen substituents on PCB
molecules, however, are chlorine atoms rather than
bromine atoms. PCB's were used as flame retard-
ants, as plasticisers, and as heat-dispersing agents
in electrical transformers. Because of their many
uses, PCB's are global contaminants, though their
current manufacture and use is restricted. Many dif-
ferent formulations of PCB's have been marketed
(for example, various Aroc/ors and Kanneclors),
and some have been reported to contain small
amounts of highly toxic chlorinated dibenzofurans
and dibenzodioxins as contaminants. The contribu-
tions of these contaminants to the effects of com-
mercial PCB mixtures in mammals is unknown.
The acute toxicity of PCB, like that of PBB, is
relatively low. Ingestion of subtoxic amounts, how-
ever, stimulates the activities of many xenobiotic
Table 3. Effects of polybrominated biphenyls (PBB) on
chloroform-induced nephrotoxicity in micea
Function
Chloroform
0.000
mi/kg
0.005
mi/kg
0.025
mi/kg
BUN, mg/dI
At 0 ppm PBB 21 4 27 4 26 3
At 1 ppm PBB 22 4 23 4 35 4
At 25 ppm PBB 22 2 22 2 47 5b
At 100 ppm PBB 21 2 28 2 81 98
PAH, S/M
AtOppmPBB 7.8 0.4 7.6 0.5 6.2 0.5
At 1 ppm PBB 7.5 0.3 5.8 0.6 4.4 0.58
At 25 ppm PBB 8.1 0.5 5.5 0.8 4.1 0.6k
At 100 ppm PBB 8.4 0.4 5.4 068 3.7 04b
a Elevations of BUN and reductions of PAH S/M are signs of
kidney injury 48 hr after i.p. chloroform (S/M is slice-to-
medium concentration ratio). Each value is the mean SEM
from six mice.
8 Significantly different from control (same dietary concentra-
tion of PBB, 0.000 mi/kg chloroform), P < 0.05. Data modified
from Kluwe and Hook [34]
metabolizing enzymes. Occupational exposure to
PCB has been reported to affect drug disposition in
man [21]. Therefore, response to metabolically acti-
vated toxicants may be altered by exposure to even
small, subtoxic amounts of PCB.
PCB induces P-450 and microsomal enzyme ac-
tivities in rodent kidney but is less potent, in this
respect, than is PBB (Table 5). Mice pretreated
with PCB were more sensitive to trichloroethylene-
and carbon tetrachloride-induced renal injury than
were naive mice [20]. Thus, exposure to PCB, like
exposure to PBB, appears to enhance the metabo-
lism of some chlorinated aliphatic hydrocarbons to
nephrotoxic products. In contrast, however, PCB
reduced the nephrotoxicity of chloroform in mice
[22]. Thus, PCB stimulation of microsomal xeno-
biotic metabolism may reduce, as well as enhance,
chlorinated hydrocarbon nephrotoxicity. The dif-
ferences between the effects of PBB and PCB in
chloroform toxicity suggest that these agents may
have different effects on the overall metabolism of
chloroform. That is, PBB and PCB, though they
share many physical and chemical characteristics,
may have qualitatively different effects on xenobiot-
ic metabolism. PCB stimulated hepatic xenobiotic
metabolism as well as renal metabolism, however,
and the serum half-life of chloroform was signifi-
cantly less in PCB-treated mice than it was in con-
trol mice (Kluwe and Hook, unpublished observa-
tions). Thus, the protective effects of PCB on
chloroform nephrotoxicity may have been a con-
sequence of increased hepatic chloroform metabo-
lism with a resulting decrease in delivery of chloro-
form to the kidney.
The effects of the various PCB mixtures and indi-
vidual components on other aspects of renal func-
tion and on the sensitivity of the kidney to other
chemical nephrotoxicants have not been defined.
Dioxins. Halogenated dibenzodioxins, often re-
ferred to simply as dioxins, are highly toxic corn-
Table 4. Effects of polybrominated biphenyls (PBB) and piperonyl butoxide pretreatments on depletion of nonprotein suiphydryl groups
by acetaminophen (APAP) in isolated perfused rat kidneysa
Pretreatment APAP in perfusate
% DepIetion of nonprotein suiphydryls
Cortex Medulla Papilla
None
PBB (150 mg/kg)
None
Piperonyl butoxide (600 mg/kg)
3 X 10-8 M
3 x l0 M
3 X 10 M
3 X 10 M
11.6
29.5
29.8
7.8
3.6
30b
4.9
39c
10.5 6.5
51.0 77b
34.9 3.3
10.9 5•5c
38.8
55.7
53.0
33.5
11.7
3.1
7.8
4.4
a Data are expressed as % depletion of nonprotein sulphydryl concentration from the nonperfused kidney of each animal. PBB and
piperonyl butoxide alone had no effect. Values represent means SEM of three to six kidneys.
" Significantly different from control (no pretreatment, 3 x 10 M APAP), P < 0.05.
Significantly different from control (no pretreatment, 3 x 10 M APAP), P < 0.05.
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Table 5. Induction of renal aryihydrocarbon hydroxylase (AHH)
activity by polybrominated biphenyls (PBB) and polychlorinated
biphenyls (PCB)a
Dietary concentration
ppm
AHH activity", % of control
PBB PCB
25 150±14e 85 6
100 310 13cd
200 466 26e, 292 12' d
400 — 478 13c,d,e
a PBB or PCB was fed to mice (in the diet) for 14 days.
b AHH activity was measured as relative fluorescence units
per milligram protein per minute, mean percent of control
SEM, N = 6 mice. Control values were 0.08 0.01.
Significantly greater than control (0 ppm), P < 0.05.
d Significantly greater than 25 ppm, P <0.05.
Significantly greater than 100 ppm of PBB or 200 ppm of
PCB, P < 0.05.
pounds. They have no commercial use but are inad-
vertently produced during the synthesis of related
chemicals. Thus, they are normally produced in
very low concentrations and are difficult to detect
by chemical methods. The most toxic of the diben-
zodioxins is 2,3 ,7,8-tetrachlorodibenzo-p -dioxin
(TCDD), which has extremely low LD50 values in
mammals (0.0006 to 0.115 mg/kg) [23]. Small
amounts of TCDD have been found in commercial
products such as the wood preservative pentachlor-
ophenol (PCP), the herbicide 2,4 ,5-trichlorophe-
noxyacetic acid (2,4,5-T), and other products syn-
thesized from chlorinated phenols. Many of the
toxic effects of the technical formulations of PCP
and 2,4,5-T may be a consequence of contamina-
tion with TCDD and other halogenated dioxins
[24, 25].
Administration of relatively large amounts of
TCDD to rodents produces direct renal injury; hy-
dronephrosis in male and female offspring of
TCDD-treated dams and degenerative changes in
kidneys of adult animals have been reported [26,
27]. Higher species, such as nonhuman primates,
appear to be more susceptible to the nephrotoxic
effects of TCDD than are lower species, such as ro-
dents. The opposite is true for the hepatotoxic
effects of TCDD. These differences may be a
consequence of species differences in TCDD dis-
tribution and disposition. A relatively smaller per-
centage of TCDD is sequestered in primate liver
than in rodent liver, whereas a larger percentage of
TCDD is excreted in primate urine than in rodent
urine [28]. Thus, the use of rodent models may un-
derestimate the nephrotoxic potential of TCDD and
related compounds in humans.
Administration of TCDD increases enzyme activ-
ities in both kidney and liver. The magnitudes of
increase, however, are generally greater in kidney
than in liver [29, 30]. Like PBB, TCDD is a potent
inducer of renal AHH but not EH or glutathione-S-
transferase (generally regarded as a detoxification
enzyme [29]). Thus, TCDD might be expected to
increase the sensitivity of the kidney to aromatic
hydrocarbon toxicity. To date, however, this possi-
bility has not been systematically investigated. Ac-
tually, in one investigation, TCDD pretreatment re-
duced the nephrotoxicity of chloroform in mice
[22]. The mechanism of this protective effect may
be similar to that suggested above for PCB (in-
creased hepatic chloroform metabolism). The
TCDD-produced change in chloroform toxicity,
however, indicates that low, subtoxic amounts of
TCDD can alter the balance between toxification
and detoxification reactions and may increase the
nephrotoxicity of certain chemicals in doses that
produce no overt signs of nephrotoxicity.
In addition to its effects on renal xenobiotic me-
tabolism, subtoxic doses of TCDD have been re-
ported to affect active transport systems in the kid-
ney. Anaizi and Cohen [31] reported that the Km of
the active excretion of phenolsulfonphthalein was
significantly reduced by administration of TCDD to
adult rats. The mechanism of this effect is un-
known. An increase in organic anion transport ca-
pacity in vitro was also reported following the ad-
ministration of phenobarbital and 3-methylchol-
anthrene (enzyme-inducing agents) to immature
rabbits [32]. Thus, enzyme-inducing agents may al-
ter aspects of kidney function other than xenobiotic
chemical metabolism.
Hexachlorobenzene (HCB). HCB is an environ-
mental pollutant that is commonly found in heavily
industrialized areas. It is used in agriculture as a
grain fumigant and is a common by-product of many
chemical manufacturing processes. It is often found
in industrial effluents and in small amounts in many
chlorinated aromatic hydrocarbon products. Like
PCB and PBB, HCB is nonpolar and tends to accu-
mulate in fatty tissues. The presence of small
amounts of halogenated dibenzodioxins and diben-
zofurans in technical grades of HCB has been re-
ported but appears to contribute little to the effects
of HCB on experimental animals [33].
Direct kidney injury by HCB has not been report-
ed. HCB is, however, a potent inducer of renal mi-
crosomal enzymes and may upset the balance be-
tween toxification and detoxification reactions.
Treatment of rats with subtoxic amounts of HCB
for 3 weeks increased the nephrotoxicity of carbon
tetrachloride (Kiuwe, Hook, unpublished observa-
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tions). The symptoms of carbon tetrachioride tox-
icity in naive and HCB-treated rats were in-
distinguishable; in HBC-treated animals, kidney in-
jury simply occurred following smaller doses of
carbon tetrachloride. These results suggest that
HCB exposure enhanced the conversion of carbon
tetrachloride to a nephrotoxic metabolite. The ef-
fects of HCB exposure on the nephrotoxicites of
other halogenated aliphatic hydrocarbons are un-
known.
Speculation. Many toxic chemicals are ingest-
ed in what would appear to be relatively innocuous
forms but are converted in the body to one or more
metabolites that are directly damaging to living tis-
sues. Changes in the relative activities of the en-
zymes that toxify or detoxify metabolically activat-
ed chemicals may alter the amount of direct tox-
icant molecules formed and, therefore, the extent of
renal injury produced. Because of this, the subtle
effects of subtoxic amounts of environmental pollu-
tants on kidney metabolism are of interest. Altera-
tions in enzymatic activity can increase or decrease
the sensitivity of the kidney to nephrotoxic chem-
icals. As discussed previously, the nephrotoxicities
of many halogenated aliphatic chemicals (for ex-
ample, chloroform and carbon tetrachloride) are al-
tered by exposure of animals to environmental con-
taminants such as PBB, PCB, HCB, and TCDD.
These results indicate that even low-level exposure
to some pollutants—those that are inducers of renal
xenobiotic metabolites—may produce deleterious
effects.
Yet to be investigated are the possible effects of
enzyme-inducing agents on other aspects of renal
metabolism such as the synthesis and degradation
of endogenous materials. Prostaglandin biosyn-
thesis involves a microsomal oxidation that occurs
in endoplasmic-reticulum-enriched fractions of both
medullary and cortical nephrons. Changes in en-
zyme activities could conceivably alter prostaglan-
din biosynthesis and, thereby, interfere with normal
renal function. The hydroxylation of 25-hydroxy-
cholecalciferol to 1 ,25-dihydroxycholecalciferol,
the form of vitamin D most active in promoting in-
testinal absorption of calcium and bone mineral mo-
bilization, is catalyzed by renal mitochondrial P-
450-dependent MFO's [35]. Thus, changes in renal
oxidative metabolism could conceivably precipitate
disorders of calcium metabolism and other homeo-
static functions.
The ever increasing number of chemicals recog-
nized as environmental contaminants and the ubiq-
uitous presence of some of these compounds in un-
avoidable sources such as ground water and air ne-
cessitates a complete understanding of their effects
on mammalian species. In the past, the toxicologic
evaluation of pollutants has concentrated on their
direct, toxic effects on experimental animals by
doses much larger than those to which humans are
likely to be exposed. The induction of xenobiotic
metabolizing enzymes, themselves, is not consid-
ered an adverse effect. It is clear, however, that al-
terations in enzymatic metabolism can change the
dose dependency of the response of experimental
animals to many toxicants. Changes in basal rates
of xenobiotic metabolism, therefore, can alter sus-
ceptibility to such agents. Most important, perhaps,
is that some environmental pollutants can alter en-
zymatic metabolism after even very low exposure,
approaching that level to which the general public
can be exposed. Thus, alterations in metabolism
may be one of the more relevant effects of organic
pollutants on mammalian species.
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